6HV-99055-45713
2 vaccinations
5 coded responses
11 check-ins
5 free-text entries
4 call cases
- Sex
- Female
- Age at first dose
- 56-60
- ZIP prefix
- 949 / CA
- Registered
- 2021-01-30
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2020-12-29
Dose 1 — Moderna
-
2021-01-27
Dose 2 — Moderna
-
2021-01-30
Registered in v-safe
- 2021-01-30
- 2021-02-01
- 2021-02-02
- 2021-02-03
-
2021-02-10
Survey response — day 14, dose 2MedDRA: Rash — Feeling: Poor · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitFree text: bad rash on handsMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-02-10
Report sent to call center — day 14, dose 2Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional1 call case(s)
-
2021-02-17
Survey response — day 21, dose 2MedDRA: Fatigue, Office visit, Pruritus, Rash — Feeling: Poor · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitFree text: Symptoms: Major and expanding diagnosed uticaria rash on torso and extremities. Fatigue due to histamine reaction. Acuity varies throuhout the day and based on activities. Signifcant itching, especially on hands and feet. · Healthcare visit (other): dermatologist visitMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-02-17
Report sent to call center — day 21, dose 2Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional1 call case(s)
-
2021-02-24
Survey response — day 28, dose 2MedDRA: Hypersensitivity, Urticaria — Feeling: Fair · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitFree text: allergic reaction doagnosed as uticaria on extremities and torso. Extensive spread requiring prescription anti histamines amd cortisone creamMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-02-24
Report sent to call center — day 28, dose 2Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional1 call case(s)
-
2021-03-03
Survey response — day 35, dose 2MedDRA: Rash — Feeling: Good · Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitFree text: previously reportrd itocaria rash symptoms are reduced. Still taking daily prescribed course of hydroxazineMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-03-03
Report sent to call center — day 35, dose 2Get care from a doctor or other healthcare professional1 call case(s)
- 2021-03-10
- 2021-04-28
- 2021-07-21
-
2021-07-30
Survey response — 6 months, dose 2MedDRA: Fatigue, Nasopharyngitis — Feeling: Good · Be unable to work or attend schoolFree text: jead cold amd fatigueMedDRA releases: 2021-09,2024-11 · check-in free text available
- 2021-11-08
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2020-12-29 | Moderna | |
| 2 | 2021-01-27 | Moderna |
Call center
4 call center cases
4 unsuccessful
2 waits over 3 months for a first call
Free text
Release 4 — day 14, dose 2
Symptoms: bad rash on hands
Release 4 — day 21, dose 2
Symptoms: Major and expanding diagnosed uticaria rash on torso and extremities. Fatigue due to histamine reaction. Acuity varies throuhout the day and based on activities. Signifcant itching, especially on hands and feet.
Healthcare visit (other): dermatologist visit
Release 4 — day 28, dose 2
Symptoms: allergic reaction doagnosed as uticaria on extremities and torso. Extensive spread requiring prescription anti histamines amd cortisone cream
Release 5 — day 35, dose 2
Symptoms: previously reportrd itocaria rash symptoms are reduced. Still taking daily prescribed course of hydroxazine
Release 9 — 6 months, dose 2
Symptoms: jead cold amd fatigue
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| HCVO | Office visit | ✓ | ✓ | ✓ |
| SD | Fatigue | ✓ | ✓ | ✓ |
| SD | Hypersensitivity | ✓ | ✓ | ✓ |
| SD | Nasopharyngitis | ✓ | · | ✓ |
| SD | Pruritus | ✓ | ✓ | ✓ |
| SD | Rash | ✓ | ✓ | ✓ |
| SD | Urticaria | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release